NO147626C - Fremgangsmaate ved fremstilling av et medisinsk preparat med forsinket frigjoering av den terapeutisk aktive bestanddel - Google Patents

Fremgangsmaate ved fremstilling av et medisinsk preparat med forsinket frigjoering av den terapeutisk aktive bestanddel

Info

Publication number: NO147626C
Authority: NO; Norway
Prior art keywords: preparation; procedure; active ingredient; delayed release; therapeutic active
Prior art date: 1976-11-26

Application number

NO774051A

Other languages

English (en)

Other versions

NO147626B (no

NO774051L (no

Inventor

Yegnaswami Raghunathan

Original Assignee

Pennwalt Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-11-26

Filing date

1977-11-25

Publication date

1983-05-25

1977-11-25 Application filed by Pennwalt Corp filed Critical Pennwalt Corp

1978-05-29 Publication of NO774051L publication Critical patent/NO774051L/no

1983-02-07 Publication of NO147626B publication Critical patent/NO147626B/no

1983-05-25 Publication of NO147626C publication Critical patent/NO147626C/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO774051A 1976-11-26 1977-11-25 Fremgangsmaate ved fremstilling av et medisinsk preparat med forsinket frigjoering av den terapeutisk aktive bestanddel NO147626C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US74532576A	1976-11-26	1976-11-26
US80010577A	1977-05-24	1977-05-24

Publications (3)

Publication Number	Publication Date
NO774051L NO774051L (no)	1978-05-29
NO147626B NO147626B (no)	1983-02-07
NO147626C true NO147626C (no)	1983-05-25

Family

ID=27114439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO774051A NO147626C (no)	1976-11-26	1977-11-25	Fremgangsmaate ved fremstilling av et medisinsk preparat med forsinket frigjoering av den terapeutisk aktive bestanddel

Country Status (21)

Country	Link
JP (1)	JPS609697B2 (no)
AR (1)	AR218047A1 (no)
AT (1)	AT359197B (no)
AU (1)	AU511080B2 (no)
BE (1)	BE861141A (no)
CA (1)	CA1086226A (no)
CH (1)	CH639560A5 (no)
DE (1)	DE2752728C2 (no)
DK (1)	DK150534C (no)
FI (1)	FI65910C (no)
FR (1)	FR2373288A1 (no)
GB (1)	GB1544761A (no)
GR (1)	GR61724B (no)
IE (1)	IE45998B1 (no)
IL (1)	IL53462A (no)
LU (1)	LU78584A1 (no)
NL (1)	NL182283C (no)
NO (1)	NO147626C (no)
NZ (1)	NZ185772A (no)
PT (1)	PT67323B (no)
SE (1)	SE426781B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2929456A1 (de)	1979-07-20	1981-02-05	Lentia Gmbh	Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) *	1984-07-18	1988-05-03	Yegnaswami Raghunathan	Controlled release pharmaceutical preparations
US4692462A (en) *	1985-03-18	1987-09-08	Menley & James Laboratories, Ltd.	Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) *	1988-08-30	1997-03-18	Pfizer Inc.	Use of asymmetric membranes in delivery devices
US5188825A (en) *	1989-12-28	1993-02-23	Iles Martin C	Freeze-dried dosage forms and methods for preparing the same
WO1992002212A2 (en) *	1990-08-07	1992-02-20	Pfizer Inc.	Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) *	1993-04-16	1995-07-25	Bristol-Myers Squibb Company	Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) *	2010-11-10	2013-09-05	Rubicon Research Private Limited	Sustained release compositions
FR3059903B1 (fr) *	2016-12-08	2019-03-22	Salsarulo Pharma	Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
IL273904B2 (en) *	2017-10-09	2024-08-01	Rhodes Pharmaceuticals Lp	Pharmaceutical resinate compositions and methods of making and using thereof
WO2020234842A1 (en) *	2019-05-23	2020-11-26	G.D Societa' Per Azioni	Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE550150A (no) *	1955-08-08
GB843118A (en) *	1957-02-13	1960-08-04	Ici Ltd	Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) *	1961-02-23	1964-11-24	White Lab Inc	Antidiarrheal compositions and method of using
GB982150A (en) *	1961-09-29	1965-02-03	Glaxo Group Ltd	Therapeutic resin complexes
US3594470A (en) *	1968-02-19	1971-07-20	Abbott Lab	Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) *	1968-03-15	1971-01-06	Philips Nv	Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) *	1968-09-03	1973-10-09	S. Banker Gilbert	Molecular drug entrapment process and compositions
CA927282A (en) *	1968-09-03	1973-05-29	S. Banker Gilbert	Entrapment compositions and processes
DE2343218C2 (de) *	1973-08-28	1986-08-07	Hoechst Ag, 6230 Frankfurt	Furosemid enthaltende Pellets

1977
- 1977-11-24 CA CA291,664A patent/CA1086226A/en not_active Expired
- 1977-11-24 NZ NZ185772A patent/NZ185772A/xx unknown
- 1977-11-24 GR GR54861A patent/GR61724B/el unknown
- 1977-11-24 FI FI773568A patent/FI65910C/fi not_active IP Right Cessation
- 1977-11-24 JP JP52140093A patent/JPS609697B2/ja not_active Expired
- 1977-11-24 GB GB48997/77A patent/GB1544761A/en not_active Expired
- 1977-11-24 BE BE182882A patent/BE861141A/xx not_active IP Right Cessation
- 1977-11-24 IL IL53462A patent/IL53462A/xx unknown
- 1977-11-25 DK DK523277A patent/DK150534C/da not_active IP Right Cessation
- 1977-11-25 LU LU78584A patent/LU78584A1/xx unknown
- 1977-11-25 AT AT848077A patent/AT359197B/de not_active IP Right Cessation
- 1977-11-25 DE DE2752728A patent/DE2752728C2/de not_active Expired
- 1977-11-25 SE SE7713370A patent/SE426781B/sv not_active IP Right Cessation
- 1977-11-25 PT PT67323A patent/PT67323B/pt unknown
- 1977-11-25 CH CH1450177A patent/CH639560A5/de not_active IP Right Cessation
- 1977-11-25 AU AU30986/77A patent/AU511080B2/en not_active Expired
- 1977-11-25 FR FR7735611A patent/FR2373288A1/fr active Granted
- 1977-11-25 AR AR270132A patent/AR218047A1/es active
- 1977-11-25 NL NLAANVRAGE7712996,A patent/NL182283C/xx not_active IP Right Cessation
- 1977-11-25 IE IE2391/77A patent/IE45998B1/en not_active IP Right Cessation
- 1977-11-25 NO NO774051A patent/NO147626C/no unknown

Also Published As

Publication number	Publication date
FR2373288B1 (no)	1980-06-13
JPS609697B2 (ja)	1985-03-12
NL182283B (nl)	1987-09-16
AR218047A1 (es)	1980-05-15
CH639560A5 (en)	1983-11-30
DK523277A (da)	1978-05-27
PT67323B (en)	1979-04-24
DK150534C (da)	1987-10-12
LU78584A1 (no)	1978-04-20
IE45998B1 (en)	1983-01-26
IE45998L (en)	1978-05-26
DK150534B (da)	1987-03-23
NL182283C (nl)	1988-02-16
NO147626B (no)	1983-02-07
SE7713370L (sv)	1978-05-27
FR2373288A1 (fr)	1978-07-07
PT67323A (en)	1977-12-01
GB1544761A (en)	1979-04-25
ATA848077A (de)	1980-03-15
IL53462A0 (en)	1978-01-31
FI65910C (fi)	1984-08-10
IL53462A (en)	1980-12-31
AU511080B2 (en)	1980-07-24
NL7712996A (nl)	1978-05-30
NO774051L (no)	1978-05-29
FI773568A (fi)	1978-05-27
AT359197B (de)	1980-10-27
DE2752728C2 (de)	1985-08-01
FI65910B (fi)	1984-04-30
JPS5369822A (en)	1978-06-21
CA1086226A (en)	1980-09-23
NZ185772A (en)	1978-12-18
AU3098677A (en)	1979-05-31
SE426781B (sv)	1983-02-14
DE2752728A1 (de)	1978-06-01
BE861141A (fr)	1978-03-16
GR61724B (en)	1978-12-29

Similar Documents

Publication	Publication Date	Title
NO149962C (no)	1984-07-25	Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO150361C (no)	1984-10-03	Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(1h-tetrazol-5-yl)-4h-(pyrido-(1,2-a)-pyrimidin-4-on-derivater
NO782127L (no)	1978-12-21	Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO148148C (no)	1983-08-17	Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO784211L (no)	1979-06-18	Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no)	1979-06-19	Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
NO151321C (no)	1985-03-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO800858L (no)	1980-09-29	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151463C (no)	1985-04-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO148957C (no)	1984-01-18	Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider
NO150360C (no)	1984-10-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO800881L (no)	1980-09-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO782756L (no)	1979-02-16	Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO147626C (no)	1983-05-25	Fremgangsmaate ved fremstilling av et medisinsk preparat med forsinket frigjoering av den terapeutisk aktive bestanddel
NO149313C (no)	1984-03-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151319C (no)	1985-03-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO149037C (no)	1984-02-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148451C (no)	1983-10-12	Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO150158C (no)	1984-08-29	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO149314C (no)	1984-03-28	Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
NO780644L (no)	1978-08-25	Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO794318L (no)	1980-07-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO152556C (no)	1985-10-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO151861C (no)	1985-06-19	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-substituert-10,11-dihydro-5h-dibenzo-(a,d)-cyclohepten-5,10-iminer
NO145656C (no)	1982-05-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater